MAP2K1 c.171G>C ;(p.K57N)

Variant ID: 15-66727455-G-C

NM_002755.3(MAP2K1):c.171G>C;(p.K57N)

This variant was identified in 112 publications

View GRCh38 version.




Publications:


Tracking and blocking interdependencies of cellular BRAF-MEK oncokinase activities.

Pnas Nexus
Fleischmann, Jakob J; Schwaighofer, Selina S; De Falco, Louis L; Enzler, Florian F; Feichtner, Andreas A; Kugler, Valentina V; Tschaikner, Philipp P; Huber, Roland G RG; Stefan, Eduard E
Publication Date: 2023-06

Variant appearance in text: MEK1: K57N
PubMed Link: 37325027
Variant Present in the following documents:
  • Main text
  • pgad185.pdf
View BVdb publication page



Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.

Frontiers In Oncology
Mauri, Gianluca G; Patelli, Giorgio G; Gori, Viviana V; Lauricella, Calogero C; Mussolin, Benedetta B; Amatu, Alessio A; Bencardino, Katia K; Tosi, Federica F; Bonazzina, Erica E; Bonoldi, Emanuela E; Bardelli, Alberto A; Siena, Salvatore S; Sartore-Bianchi, Andrea A
Publication Date: 2023

Variant appearance in text: MAP2K1: K57N
PubMed Link: 37056342
Variant Present in the following documents:
  • fonc-13-1147497.pdf
View BVdb publication page



Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.

Nature
Abbosh, Christopher C; Frankell, Alexander M AM; Harrison, Thomas T; Kisistok, Judit J; Garnett, Aaron A; Johnson, Laura L; Veeriah, Selvaraju S; Moreau, Mike M; Chesh, Adrian A; Chaunzwa, Tafadzwa L TL; Weiss, Jakob J; Schroeder, Morgan R MR; Ward, Sophia S; Grigoriadis, Kristiana K; Shahpurwalla, Aamir A; Litchfield, Kevin K; Puttick, Clare C; Biswas, Dhruva D; Karasaki, Takahiro T; Black, James R M JRM; Martínez-Ruiz, Carlos C; Bakir, Maise Al MA; Pich, Oriol O; Watkins, Thomas B K TBK; Lim, Emilia L EL; Huebner, Ariana A; Moore, David A DA; Godin-Heymann, Nadia N; L'Hernault, Anne A; Bye, Hannah H; Odell, Aaron A; Roberts, Paula P; Gomes, Fabio F; Patel, Akshay J AJ; Manzano, Elizabeth E; Hiley, Crispin T CT; Carey, Nicolas N; Riley, Joan J; Cook, Daniel E DE; Hodgson, Darren D; Stetson, Daniel D; Barrett, J Carl JC; Kortlever, Roderik M RM; Evan, Gerard I GI; Hackshaw, Allan A; Daber, Robert D RD; Shaw, Jacqui A JA; Aerts, Hugo J W L HJWL; Licon, Abel A; Stahl, Josh J; Jamal-Hanjani, Mariam M; , ; Birkbak, Nicolai J NJ; McGranahan, Nicholas N; Swanton, Charles C
Publication Date: 2023-04-13

Variant appearance in text: MAP2K1: K57N
PubMed Link: 37055640
Variant Present in the following documents:
  • EMS176197-supplement-Supplementary_Table_1.xlsx, sheet 18
View BVdb publication page



Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues.

Nature Communications
Abelin, Jennifer G JG; Bergstrom, Erik J EJ; Rivera, Keith D KD; Taylor, Hannah B HB; Klaeger, Susan S; Xu, Charles C; Verzani, Eva K EK; Jackson White, C C; Woldemichael, Hilina B HB; Virshup, Maya M; Olive, Meagan E ME; Maynard, Myranda M; Vartany, Stephanie A SA; Allen, Joseph D JD; Phulphagar, Kshiti K; Harry Kane, M M; Rachimi, Suzanna S; Mani, D R DR; Gillette, Michael A MA; Satpathy, Shankha S; Clauser, Karl R KR; Udeshi, Namrata D ND; Carr, Steven A SA
Publication Date: 2023-04-03

Variant appearance in text: MAP2K1: K57N
PubMed Link: 37012232
Variant Present in the following documents:
  • 41467_2023_37547_MOESM12_ESM.xlsx, sheet 3
  • 41467_2023_37547_MOESM10_ESM.xlsx, sheet 3
  • 41467_2023_37547_MOESM12_ESM.xlsx, sheet 2
View BVdb publication page



Direct GDP-KRASG12C inhibitors and mechanisms of resistance: the tip of the iceberg.

Therapeutic Advances In Medical Oncology
Rosen, Joshua C JC; Sacher, Adrian A; Tsao, Ming-Sound MS
Publication Date: 2023

Variant appearance in text: MEK1: K57N
PubMed Link: 36950276
Variant Present in the following documents:
  • Main text
  • 10.1177_17588359231160141.pdf
View BVdb publication page



Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry.

Cancer Research Communications
White, Jason A JA; Kaninjing, Ernest T ET; Adeniji, Kayode A KA; Jibrin, Paul P; Obafunwa, John O JO; Ogo, Chidiebere N CN; Mohammed, Faruk F; Popoola, Ademola A; Fatiregun, Omolara A OA; Oluwole, Olabode P OP; Karanam, Balasubramanyam B; Elhussin, Isra I; Ambs, Stefan S; Tang, Wei W; Davis, Melissa M; Polak, Paz P; Campbell, Moray J MJ; Brignole, Kathryn R KR; Rotimi, Solomon O SO; Dean-Colomb, Windy W; Odedina, Folake T FT; Martin, Damali N DN; Yates, Clayton C
Publication Date: 2022-09

Variant appearance in text: MAP2K1: 171G>C; K57N; rs869025608
PubMed Link: 36922933
Variant Present in the following documents:
  • crc-22-0136-s01.xlsx, sheet 3
View BVdb publication page



Network expansion of genetic associations defines a pleiotropy map of human cell biology.

Nature Genetics
Barrio-Hernandez, Inigo I; Schwartzentruber, Jeremy J; Shrivastava, Anjali A; Del-Toro, Noemi N; Gonzalez, Asier A; Zhang, Qian Q; Mountjoy, Edward E; Suveges, Daniel D; Ochoa, David D; Ghoussaini, Maya M; Bradley, Glyn G; Hermjakob, Henning H; Orchard, Sandra S; Dunham, Ian I; Anderson, Carl A CA; Porras, Pablo P; Beltrao, Pedro P
Publication Date: 2023-02-23

Variant appearance in text: MAP2K1: 171G>C; Lys57Asn
PubMed Link: 36823319
Variant Present in the following documents:
  • 41588_2023_1327_MOESM4_ESM.xlsx, sheet 6
View BVdb publication page



Caspase 3-specific cleavage of MEK1 suppresses ERK signaling and sensitizes cells to stress-induced apoptosis.

Febs Open Bio
Moriizumi, Hisashi H; Kubota, Yuji Y; Tsuchiya, Tomoyuki T; Naka, Ryosuke R; Takekawa, Mutsuhiro M
Publication Date: 2023-02-13

Variant appearance in text: MEK1: K57N
PubMed Link: 36776127
Variant Present in the following documents:
  • Main text
  • FEB4-13-684.pdf
View BVdb publication page



Combined KRAS G12C and SOS1 inhibition enhances and extends the anti-tumor response in KRAS G12C -driven cancers by addressing intrinsic and acquired resistance.

Biorxiv : The Preprint Server For Biology
Thatikonda, Venu V; Lu, Hengyu H; Jurado, Sabine S; Kostyrko, Kaja K; Bristow, Christopher A CA; Bosch, Karin K; Feng, Ningping N; Gao, Sisi S; Gerlach, Daniel D; Gmachl, Michael M; Lieb, Simone S; Jeschko, Astrid A; Machado, Annette A AA; Marszalek, Ethan D ED; Mahendra, Mikhila M; Jaeger, Philipp A PA; Sorokin, Alexey A; Strauss, Sandra S; Trapani, Francesca F; Kopetz, Scott S; Vellano, Christopher P CP; Petronczki, Mark M; Kraut, Norbert N; Heffernan, Timothy P TP; Marszalek, Joseph R JR; Pearson, Mark M; Waizenegger, Irene I; Hofmann, Marco H MH
Publication Date: 2023-01-23

Variant appearance in text: MAP2K1: K57N
PubMed Link: 36747713
Variant Present in the following documents:
  • media-1.xlsx, sheet 4
View BVdb publication page



Characterization of driver mutations in Chinese non-small cell lung cancer patients using a novel targeted sequencing panel.

Journal Of Thoracic Disease
Zhao, Jing J; Wu, Yang Y; Chen, Min-Jiang MJ; Xu, Yan Y; Zhong, Wei W; Wang, Meng-Zhao MZ
Publication Date: 2022-12

Variant appearance in text: MAP2K1: K57N
PubMed Link: 36647494
Variant Present in the following documents:
  • Main text
  • jtd-14-12-4669.pdf
View BVdb publication page



Clinical utility of liquid biopsy and integrative genomic profiling in early-stage and oligometastatic cancer patients treated with radiotherapy.

British Journal Of Cancer
Cifuentes, Guadalupe A GA; Santiago, Adrián A; Méndez Blanco, Lucía L; Fueyo, María M; López Martínez, Esther E; Soria, Raquel R; Martín López, Irene I; Cucarella Beltrán, Pepa P; Pardo-Coto, Pablo P; Rodriguez-Rubi, David D; Urquilla, Karla K; Durán, Noelia S NS; Álvarez, Rebeca R; Lago, Claudia G CG; Otero, Andrea A; Diñeiro, Marta M; Capín, Raquel R; Cadiñanos, Juan J; Cabanillas, Rubén R
Publication Date: 2022-12-22

Variant appearance in text: MAP2K1: Lys57Asn
PubMed Link: 36550207
Variant Present in the following documents:
  • Main text
  • 41416_2022_Article_2102.pdf
View BVdb publication page



Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer.

Molecular Biomedicine
Wang, Zixi Z; Xing, Yurou Y; Li, Bingjie B; Li, Xiaoyu X; Liu, Bin B; Wang, Yongsheng Y
Publication Date: 2022-12-12

Variant appearance in text: MEK1: K57N
PubMed Link: 36508072
Variant Present in the following documents:
  • Main text
  • 43556_2022_Article_107.pdf
View BVdb publication page



High-throughput functional evaluation of MAP2K1 variants in cancer.

Molecular Cancer Therapeutics
Mizuno, Sho S; Ikegami, Masachika M; Koyama, Takafumi T; Sunami, Kuniko K; Ogata, Dai D; Kage, Hidenori H; Yanagaki, Mitsuru M; Ikeuchi, Hiroshi H; Ueno, Toshihide T; Tanikawa, Michihiro M; Oda, Katsutoshi K; Osuga, Yutaka Y; Mano, Hiroyuki H; Kohsaka, Shinji S
Publication Date: 2022-11-28

Variant appearance in text: MAP2K1: K57N
PubMed Link: 36442478
Variant Present in the following documents:
  • Main text
  • mct-22-0302_supplementary_tables_suppst.xlsx, sheet 7
  • 227.pdf
  • mct-22-0302_supplementary_tables_suppst.xlsx, sheet 8
  • mct-22-0302_supplementary_tables_suppst.xlsx, sheet 3
View BVdb publication page



Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.

Frontiers In Oncology
Mauri, Gianluca G; Patelli, Giorgio G; Gori, Viviana V; Lauricella, Calogero C; Mussolin, Benedetta B; Amatu, Alessio A; Bencardino, Katia K; Tosi, Federica F; Bonazzina, Erica E; Bonoldi, Emanuela E; Bardelli, Alberto A; Siena, Salvatore S; Sartore-Bianchi, Andrea A
Publication Date: 2022

Variant appearance in text: MAP2K1: K57N
PubMed Link: 36419886
Variant Present in the following documents:
  • Main text
  • fonc-12-1030232.pdf
View BVdb publication page



Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: MAP2K1: K57N
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers.

Cancers
Cekani, Elona E; Epistolio, Samantha S; Dazio, Giulia G; Cefalì, Marco M; Wannesson, Luciano L; Frattini, Milo M; Froesch, Patrizia P
Publication Date: 2022-08-24

Variant appearance in text: MAP2K1: 171G>C; K57N
PubMed Link: 36077640
Variant Present in the following documents:
  • Main text
  • cancers-14-04103.pdf
View BVdb publication page



Clinical characteristics of 10 Chinese patients with melorheostosis and identification of a somatic MAP2K1 variant in one case.

Molecular Genetics & Genomic Medicine
Han, Xiaojun X; Xu, Yang Y; Wei, Zhanying Z; Wang, Chun C; Yue, Hua H; Zhang, Zhenlin Z
Publication Date: 2022-10

Variant appearance in text: MEK1: Lys57Asn
PubMed Link: 36004822
Variant Present in the following documents:
  • Main text
  • MGG3-10-e2043.pdf
View BVdb publication page



Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features.

The American Journal Of Surgical Pathology
Lim, Sojung S; Lim, Ka Young KY; Koh, Jiwon J; Bae, Jeong Mo JM; Yun, Hongseok H; Lee, Cheol C; Kim, Young A YA; Paik, Jin Ho JH; Jeon, Yoon Kyung YK
Publication Date: 2022-10-01

Variant appearance in text: MAP2K1: K57N
PubMed Link: 35834399
Variant Present in the following documents:
  • pas-46-1397-s003.xlsx, sheet 1
View BVdb publication page



Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer.

Nature Communications
Kubota, Yuji Y; Fujioka, Yuko Y; Patil, Ashwini A; Takagi, Yusuke Y; Matsubara, Daisuke D; Iijima, Masatomi M; Momose, Isao I; Naka, Ryosuke R; Nakai, Kenta K; Noda, Nobuo N NN; Takekawa, Mutsuhiro M
Publication Date: 2022-07-13

Variant appearance in text: MEK1: K57N
PubMed Link: 35831322
Variant Present in the following documents:
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 19
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 21
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 15
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 92
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 52
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 4
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 78
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 22
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 50
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 17
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 20
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 16
  • 41467_2022_31690_MOESM7_ESM.xlsx, sheet 14
View BVdb publication page



Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells.

Nature Communications
Robinson, Philip S PS; Thomas, Laura E LE; Abascal, Federico F; Jung, Hyunchul H; Harvey, Luke M R LMR; West, Hannah D HD; Olafsson, Sigurgeir S; Lee, Bernard C H BCH; Coorens, Tim H H THH; Lee-Six, Henry H; Butlin, Laura L; Lander, Nicola N; Truscott, Rebekah R; Sanders, Mathijs A MA; Lensing, Stefanie V SV; Buczacki, Simon J A SJA; Ten Hoopen, Rogier R; Coleman, Nicholas N; Brunton-Sim, Roxanne R; Rushbrook, Simon S; Saeb-Parsy, Kourosh K; Lalloo, Fiona F; Campbell, Peter J PJ; Martincorena, Iñigo I; Sampson, Julian R JR; Stratton, Michael R MR
Publication Date: 2022-07-08

Variant appearance in text: N/A
PubMed Link: 35803914
Variant Present in the following documents:
View BVdb publication page



Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma.

Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc
Xiang, Chan C; Ji, Chunyu C; Cai, Yiran Y; Teng, Haohua H; Wang, Yulu Y; Zhao, Ruiying R; Shang, Zhanxian Z; Guo, Lianying L; Chen, Shengnan S; Lizaso, Analyn A; Lin, Jing J; Wang, Haozhe H; Li, Bing B; Zhang, Zhou Z; Zhao, Jikai J; Wei, Jinzhi J; Liu, Jiaxin J; Zhu, Lei L; Fang, Wentao W; Han, Yuchen Y
Publication Date: 2022-09

Variant appearance in text: N/A
PubMed Link: 35641658
Variant Present in the following documents:
View BVdb publication page



Author Correction: Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.

Nature Communications
Farshidfar, Farshad F; Rhrissorrakrai, Kahn K; Levovitz, Chaya C; Peng, Cong C; Knight, James J; Bacchiocchi, Antonella A; Su, Juan J; Yin, Mingzhu M; Sznol, Mario M; Ariyan, Stephan S; Clune, James J; Olino, Kelly K; Parida, Laxmi L; Nikolaus, Joerg J; Zhang, Meiling M; Zhao, Shuang S; Wang, Yan Y; Huang, Gang G; Wan, Miaojian M; Li, Xianan X; Cao, Jian J; Yan, Qin Q; Chen, Xiang X; Newman, Aaron M AM; Halaban, Ruth R
Publication Date: 2022-05-10

Variant appearance in text: MAP2K1: K57N
PubMed Link: 35538087
Variant Present in the following documents:
  • 41467_2022_30446_MOESM1_ESM.xlsx, sheet 2
View BVdb publication page



Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.

Cancers
Maitre, Elsa E; Tomowiak, Cécile C; Lebecque, Benjamin B; Bijou, Fontanet F; Benabed, Khaled K; Naguib, Dina D; Kerneves, Pauline P; Cornet, Edouard E; Viailly, Pierre-Julien PJ; Arsham, Jeffrey J; Sola, Brigitte B; Jardin, Fabrice F; Troussard, Xavier X
Publication Date: 2022-04-10

Variant appearance in text: MAP2K1: K57N
PubMed Link: 35454811
Variant Present in the following documents:
  • Main text
View BVdb publication page



ISSVA Classification of Vascular Anomalies and Molecular Biology.

International Journal Of Molecular Sciences
Kunimoto, Kayo K; Yamamoto, Yuki Y; Jinnin, Masatoshi M
Publication Date: 2022-02-21

Variant appearance in text: MAP2K1: K57N
PubMed Link: 35216474
Variant Present in the following documents:
  • Main text
  • ijms-23-02358.pdf
View BVdb publication page



Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.

Nature Communications
Farshidfar, Farshad F; Rhrissorrakrai, Kahn K; Levovitz, Chaya C; Peng, Cong C; Knight, James J; Bacchiocchi, Antonella A; Su, Juan J; Yin, Mingzhu M; Sznol, Mario M; Ariyan, Stephan S; Clune, James J; Olino, Kelly K; Parida, Laxmi L; Nikolaus, Joerg J; Zhang, Meiling M; Zhao, Shuang S; Wang, Yan Y; Huang, Gang G; Wan, Miaojian M; Li, Xianan X; Cao, Jian J; Yan, Qin Q; Chen, Xiang X; Newman, Aaron M AM; Halaban, Ruth R
Publication Date: 2022-02-23

Variant appearance in text: MAP2K1: K57N
PubMed Link: 35197475
Variant Present in the following documents:
  • 41467_2022_28566_MOESM5_ESM.xlsx, sheet 2
View BVdb publication page



Next Generation Sequencing Reveals Pathogenic and Actionable Genetic Alterations of Soft Tissue Sarcoma in Chinese Patients: A Single Center Experience.

Technology In Cancer Research & Treatment
Jin, Gu G; Wang, Chunyang C; Jia, Dongdong D; Qian, Wenkang W; Yin, Chunming C; Wang, Danhua D; Yang, Quanyu Q; Li, Tao T; Zheng, Aiwen A
Publication Date: 2021

Variant appearance in text: MAP2K1: K57N
PubMed Link: 34939467
Variant Present in the following documents:
  • Main text
  • 10.1177_15330338211068964.pdf
View BVdb publication page



Next Generation Sequencing Reveals Pathogenic and Actionable Genetic Alterations of Soft Tissue Sarcoma in Chinese Patients: A Single Center Experience.

Technology In Cancer Research & Treatment
Jin, Gu G; Wang, Chunyang C; Jia, Dongdong D; Qian, Wenkang W; Yin, Chunming C; Wang, Danhua D; Yang, Quanyu Q; Li, Tao T; Zheng, Aiwen A
Publication Date: 2021

Variant appearance in text: MAP2K1: K57N
PubMed Link: 34939467
Variant Present in the following documents:
  • Main text
  • 10.1177_15330338211068964.pdf
View BVdb publication page



Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer.

Cancers
Sunaga, Noriaki N; Miura, Yosuke Y; Kasahara, Norimitsu N; Sakurai, Reiko R
Publication Date: 2021-11-26

Variant appearance in text: MEK1: K57N
PubMed Link: 34885068
Variant Present in the following documents:
  • cancers-13-05956.pdf
View BVdb publication page



Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer.

Cancers
Sunaga, Noriaki N; Miura, Yosuke Y; Kasahara, Norimitsu N; Sakurai, Reiko R
Publication Date: 2021-11-26

Variant appearance in text: MEK1: K57N
PubMed Link: 34885068
Variant Present in the following documents:
  • cancers-13-05956.pdf
View BVdb publication page



DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition.

Cancer Discovery
Izquierdo, Elisa E; Carvalho, Diana M DM; Mackay, Alan A; Temelso, Sara S; Boult, Jessica K R JKR; Pericoli, Giulia G; Fernandez, Elisabet E; Das, Molina M; Molinari, Valeria V; Grabovska, Yura Y; Rogers, Rebecca F RF; Ajmone-Cat, Maria Antonietta MA; Proszek, Paula Z PZ; Stubbs, Mark M; Depani, Sarita S; O'Hare, Patricia P; Yu, Lu L; Roumelioti, Georgia G; Choudhary, Jyoti S JS; Clarke, Matthew M; Fairchild, Amy R AR; Jacques, Thomas S TS; Grundy, Richard G RG; Howell, Lisa L; Picton, Susan S; Adamski, Jenny J; Wilson, Shaun S; Gray, Juliet C JC; Zebian, Bassel B; Marshall, Lynley V LV; Carceller, Fernando F; Grill, Jacques J; Vinci, Maria M; Robinson, Simon P SP; Hubank, Michael M; Hargrave, Darren D; Jones, Chris C
Publication Date: 2022-03-01

Variant appearance in text: MEK1: K57N
PubMed Link: 34737188
Variant Present in the following documents:
  • Main text
  • 712.pdf
View BVdb publication page



Concurrent presentation of brain arteriovenous malformation, peripheral arteriovenous malformation, and cerebellar astrocytoma: Case report.

Interdisciplinary Neurosurgery : Advanced Techniques And Case Management
Gautam, Ayushi A; Sun, Zhengda Z; Winkler, Ethan E; Su, Hua H; McCalmont, Timothy H TH; Kim, Helen H; Tihan, Tarik T; Hoffman, William Y WY; Dowd, Chris F CF; Frieden, Ilona J IJ; Cooke, Daniel L DL
Publication Date: 2020-06

Variant appearance in text: MAP2K1: K57N
PubMed Link: 34307056
Variant Present in the following documents:
  • Main text
View BVdb publication page



Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.

Genome Medicine
Vangala, Deepak D; Ladigan, Swetlana S; Liffers, Sven T ST; Noseir, Soha S; Maghnouj, Abdelouahid A; Götze, Tina-Maria TM; Verdoodt, Berlinda B; Klein-Scory, Susanne S; Godfrey, Laura L; Zowada, Martina K MK; Huerta, Mario M; Edelstein, Daniel L DL; de Villarreal, Jaime Martinez JM; Marqués, Miriam M; Kumbrink, Jörg J; Jung, Andreas A; Schiergens, Tobias T; Werner, Jens J; Heinemann, Volker V; Stintzing, Sebastian S; Lindoerfer, Doris D; Mansmann, Ulrich U; Pohl, Michael M; Teschendorf, Christian C; Bernhardt, Christiane C; Wolters, Heiner H; Stern, Josef J; Usta, Selami S; Viebahn, Richard R; Admard, Jacob J; Casadei, Nicolas N; Fröhling, Stefan S; Ball, Claudia R CR; Siveke, Jens T JT; Glimm, Hanno H; Tannapfel, Andrea A; Schmiegel, Wolff W; Hahn, Stephan A SA
Publication Date: 2021-07-16

Variant appearance in text: MAP2K1: K57N
PubMed Link: 34271981
Variant Present in the following documents:
  • Main text
  • 13073_2021_Article_926.pdf
View BVdb publication page



A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma.

Journal Of Experimental & Clinical Cancer Research : Cr
Mlakar, Vid V; Morel, Edouard E; Mlakar, Simona Jurkovic SJ; Ansari, Marc M; Gumy-Pause, Fabienne F
Publication Date: 2021-06-08

Variant appearance in text: MAP2K1: K57N
PubMed Link: 34103089
Variant Present in the following documents:
  • Main text
  • 13046_2021_Article_1967.pdf
View BVdb publication page



Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients.

Breast Cancer Research And Treatment
Nteliopoulos, Georgios G; Page, Karen K; Hills, Allison A; Howarth, Karen K; Emmett, Warren W; Green, Emma E; Martinson, Luke J LJ; Fernadez-Garcia, Daniel D; Hastings, Robert R; Guttery, David S DS; Kenny, Laura L; Stebbing, Justin J; Cleator, Susan S; Rehman, Farah F; Gleason, Kelly L T KLT; Sanela, Andrijac A; Ion, Charlotte C; Rushton, Amelia J AJ; Rosenfeld, Nitzan N; Coombes, R Charles RC; Shaw, Jacqueline A JA
Publication Date: 2021-07

Variant appearance in text: MAP2K1: K57N
PubMed Link: 34097174
Variant Present in the following documents:
  • 10549_2021_6220_MOESM2_ESM.xlsx, sheet 2
View BVdb publication page



Peritoneal or mesenteric tumours revealing histiocytosis.

Bmj Open Gastroenterology
Cohen-Aubart, Fleur F; Ungureanu, Irena I; Razanamahery, Jerome J; Charlotte, Frédéric F; Valmary-Degano, Séverine S; Hélias-Rodzewicz, Zofia Z; Cazals-Hatem, Dominique D; Dartigues, Peggy P; Delage-Corre, Manuela M; Selves, Janick J; Tas, Patrick P; Humbert, Sebastien S; Malakhia, Alexandre A; Kunnamo, Merja M; Veresezan, Liana L; Prokopiou, Chrystalla C; Seeber, Andreas A; Tazi, Abdellatif A; Donadieu, Jean J; Lucidarme, Olivier O; Haroche, Julien J; Emile, Jean-François JF
Publication Date: 2021-05

Variant appearance in text: MAP2K1: Lys57Asn
PubMed Link: 34020934
Variant Present in the following documents:
  • Main text
View BVdb publication page



Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer.

Journal Of Hematology & Oncology
Chen, Gong G; Peng, Junjie J; Xiao, Qian Q; Wu, Hao-Xiang HX; Wu, Xiaojun X; Wang, Fulong F; Li, Liren L; Ding, Peirong P; Zhao, Qi Q; Li, Yaqi Y; Wang, Da D; Shao, Yang Y; Bao, Hua H; Pan, Zhizhong Z; Ding, Ke-Feng KF; Cai, Sanjun S; Wang, Feng F; Xu, Rui-Hua RH
Publication Date: 2021-05-17

Variant appearance in text: MAP2K1: K57N
PubMed Link: 34001194
Variant Present in the following documents:
  • 13045_2021_1089_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page



Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC).

Journal For Immunotherapy Of Cancer
Ricciuti, Biagio B; Jones, Greg G; Severgnini, Mariano M; Alessi, Joao V JV; Recondo, Gonzalo G; Lawrence, Marissa M; Forshew, Tim T; Lydon, Christine C; Nishino, Mizuki M; Cheng, Michael M; Awad, Mark M
Publication Date: 2021-03

Variant appearance in text: MAP2K1: K57N
PubMed Link: 33771889
Variant Present in the following documents:
  • jitc-2020-001504supp002.pdf
View BVdb publication page



Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant.

Oncotargets And Therapy
Liu, Qiuying Q; Harris, Nicholas N; Epperla, Narendranath N; Andritsos, Leslie A LA
Publication Date: 2021

Variant appearance in text: MAP2K1: K57N
PubMed Link: 33727830
Variant Present in the following documents:
  • Main text
  • ott-14-1797.pdf
View BVdb publication page



Understanding protein structural changes for oncogenic missense variants.

Heliyon
Hernandez, Rolando R; Facelli, Julio C JC
Publication Date: 2021-01

Variant appearance in text: MAP2K1: Lys57Asn
PubMed Link: 33553733
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications
Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q
Publication Date: 2021-01-04

Variant appearance in text: MAP2K1: 171G>C; K57N
PubMed Link: 33397889
Variant Present in the following documents:
  • 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1
  • 41467_2020_20162_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy.

Cancers
Knebel, Franciele H FH; Barber, Louise J LJ; Newey, Alice A; Kleftogiannis, Dimitrios D; Woolston, Andrew A; Griffiths, Beatrice B; Fenwick, Kerry K; Bettoni, Fabiana F; Ribeiro, Maurício Fernando Silva Almeida MFSA; da Fonseca, Leonardo L; Costa, Frederico F; Capareli, Fernanda Cunha FC; Hoff, Paulo M PM; Sabbaga, Jorge J; Camargo, Anamaria A AA; Gerlinger, Marco M
Publication Date: 2020-12-11

Variant appearance in text: MEK1: K57N
PubMed Link: 33322618
Variant Present in the following documents:
  • Main text
  • cancers-12-03736.pdf
  • cancers-12-03736-s001.pdf
View BVdb publication page



Mutation-oriented profiling of autoinhibitory kinase conformations predicts RAF inhibitor efficacies.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Mayrhofer, Johanna E JE; Enzler, Florian F; Feichtner, Andreas A; Röck, Ruth R; Fleischmann, Jakob J; Raffeiner, Andrea A; Tschaikner, Philipp P; Ogris, Egon E; Huber, Roland G RG; Hartl, Markus M; Schneider, Rainer R; Troppmair, Jakob J; Torres-Quesada, Omar O; Stefan, Eduard E
Publication Date: 2020-12-08

Variant appearance in text: MEK1: K57N
PubMed Link: 33229534
Variant Present in the following documents:
  • Main text
View BVdb publication page